September 20, 2017 10:06 AM ET


Company Overview of Aclaris Therapeutics, Inc.

Executive Profile

Christopher V. Powala

Co-Founder and Chief Operating Officer, Aclaris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Member in 0 organization across 3 different industries.

As of Fiscal Year 2016


Mr. Christopher V. Powala co-founded Aclaris Therapeutics, Inc. in July 2012 and has been its Chief Operating Officer since July 2012. Mr. Powala co-founded Vicept Therapeutics, Inc. in 2009 and served as its Chief Operating Officer. He served as Vice President of Regulatory Affairs & Clinical Operations of Vital Therapies, Inc. He has over 23 years of experience in the pharmaceutical industry and over 20 years in regulatory affairs and drug development. Prior to Vital ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 484-324-7933
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.


Bachelor's Degree
Regents College, London

Other Affiliations

Annual Compensation

Total Annual Compensation$345,000

Stocks Options

Restricted Stock Awards$300,768
All Other Compensation$11,717
Exercisable Options$64,463
Exercisable Options Value$1,084,516
Unexercisable Options$179,826
Unexercisable Options Value$1,451,252
Total Value of Options$2,535,768
Total Number of Options$244,289

Total Compensation

Total Annual Cash Compensation$477,467
Total Short Term Compensation$345,000
Other Long Term Compensation$312,485
Total Calculated Compensation$2,175,995

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aclaris Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at